NVR ZY1 (Zykadia 150 mg)
Generic Name: ceritinib
Pill with imprint NVR ZY1 is Blue, Round and has been identified as Zykadia 150 mg. It is supplied by Novartis Pharmaceuticals Corporation.
Zykadia is used in the treatment of non-small cell lung cancer and belongs to the drug class multikinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Zykadia 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NVR ZY1
Zykadia
- Generic Name
- ceritinib
- Imprint
- NVR ZY1
- Strength
- 150 mg
- Color
- Blue
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Novartis Pharmaceuticals Corporation
- National Drug Code (NDC)
- 00078-0694
More about Zykadia (ceritinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.